Cosome-E Cough Suspension 120ml

Indications

Cosome-E Cough Suspension 120ml is primarily indicated in conditions like Acute urticaria, Advanced ovarian cancer, Allergic conjunctivitis, Angiooedema, Atopic dermatitis, Chronic urticaria, Emergency treatment of anaphylactic reaction, Seasonal allergic rhinitis, Transcervical operative procedures in first trimester, and can also be given in adjunctive therapy as an alternative drug of choice in Common cold.

Contraindication

Cosome-E Cough Suspension 120ml is contraindicated in conditions like Hypersensitivity.

Side Effects

The severe or irreversible adverse effects of Cosome-E Cough Suspension 120ml, which give rise to further complications include Sinus tachycardia, Jaundice, Jaundice, Seizures, Hypertension, CNS stimulation. Cosome-E Cough Suspension 120ml produces potentially life-threatening effects which include Bone marrow suppression, which are responsible for the discontinuation of Cosome-E Cough Suspension 120ml therapy. The signs and symptoms that are produced after the acute overdosage of Cosome-E Cough Suspension 120ml include Hypotension, Convulsions, Comag Urinary retention, Unconsciousness, Fever, Dryness of mucous, Flushing membraneg Pupillary dilatation. The symptomatic adverse reactions produced by Cosome-E Cough Suspension 120ml are more or less tolerable and if they become severe, they can be treated symptomatically, these include Drowsiness, Fatigue, Nausea, vomiting, Restlessness, Palpitation, Constipation, Abdominal pain, Dry mouth, Blurred vision, Sedation, Polyuria, Facial dyskinesias, Blood dyscrasias, Xerostomia, Dry mouth.

Warnings

Chlorpheniramine should be used with caution in bone marrow depression. Patients should observe caution while driving or performing other task requiring alertness because it may cause drowsiness. It should be used with caution in patients with urinary retention, history of bronchial asthma, hyperthyroidism, cardiovascular or liver disease. It should be used with caution in person with acute or chronic respiratory impairment, especially in children. Do not administer subcutaneously because irritation or lesion may occur.